Literature DB >> 10226707

Synthesis and properties of hydroxyapatite/poly-L-lactide composite biomaterials.

N Ignjatović1, S Tomić, M Dakić, M Miljković, M Plavsić, D Uskoković.   

Abstract

Calcium hydroxyapatite (HAp) and poly-L-lactide (PLLA) were synthesized chemically. The obtained HAp was of high purity and, after special thermal treatment, of high crystallinity as well. Synthesis of PLLA was performed using L-lactide as a monomer and nontoxic initiator. In this way a polymer of large molar weight (about 400,000) was obtained. The HAp and PLLA obtained were used as constituents of the HAp/PLLA composite biomaterial, a potential material for implants. The composite was obtained by mixing completely dissolved PLLA with granules of HAp. The composite was compacted by cold and hot pressing at pressures of 49.0-490.5 MPa and temperatures of 20-184 degrees C. The material obtained at optimum process parameters had a density of 99.6% and compressive strength of 93.2 MPa.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10226707     DOI: 10.1016/s0142-9612(98)00234-8

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  10 in total

1.  New biocomposite [biphasic calcium phosphate/ poly-DL-lactide-co-glycolide/biostimulative agent] filler for reconstruction of bone tissue changed by osteoporosis.

Authors:  N Ignjatovic; Z Ajdukovic; D Uskokovic
Journal:  J Mater Sci Mater Med       Date:  2005-07       Impact factor: 3.896

2.  Bioactivation of calcium deficient hydroxyapatite with foamed gelatin gel. A new injectable self-setting bone analogue.

Authors:  M Dessì; M A Alvarez-Perez; R De Santis; M P Ginebra; J A Planell; L Ambrosio
Journal:  J Mater Sci Mater Med       Date:  2013-10-18       Impact factor: 3.896

3.  Osteogenic activity of MG63 cells on bone-like hydroxyapatite/collagen nanocomposite sponges.

Authors:  Teruaki Yoshida; Masanori Kikuchi; Yoshihisa Koyama; Kazuo Takakuda
Journal:  J Mater Sci Mater Med       Date:  2009-11-19       Impact factor: 3.896

Review 4.  Biocomposites and hybrid biomaterials based on calcium orthophosphates.

Authors:  Sergey V Dorozhkin
Journal:  Biomatter       Date:  2011 Jul-Sep

5.  Heparinized hydroxyapatite/collagen three-dimensional scaffolds for tissue engineering.

Authors:  S Teixeira; L Yang; P J Dijkstra; M P Ferraz; F J Monteiro
Journal:  J Mater Sci Mater Med       Date:  2010-07-02       Impact factor: 3.896

6.  Bone tissue engineering with premineralized silk scaffolds.

Authors:  Hyeon Joo Kim; Ung-Jin Kim; Hyun Suk Kim; Chunmei Li; Masahisa Wada; Gary G Leisk; David L Kaplan
Journal:  Bone       Date:  2008-03-04       Impact factor: 4.398

7.  Carbon nanotubes in nanocomposites and hybrids with hydroxyapatite for bone replacements.

Authors:  Ueon Sang Shin; Il-Kyu Yoon; Gil-Su Lee; Won-Cheoul Jang; Jonathan C Knowles; Hae-Won Kim
Journal:  J Tissue Eng       Date:  2011-05-25       Impact factor: 7.813

8.  Reformulating Tylocrebrine in Epidermal Growth Factor Receptor Targeted Polymeric Nanoparticles Improves Its Therapeutic Index.

Authors:  Ameya R Kirtane; Henry L Wong; Bharath Raja Guru; Lev G Lis; Gunda I Georg; Vadim J Gurvich; Jayanth Panyam
Journal:  Mol Pharm       Date:  2015-07-03       Impact factor: 4.939

Review 9.  Geometric Modeling of Cellular Materials for Additive Manufacturing in Biomedical Field: A Review.

Authors:  Gianpaolo Savio; Stefano Rosso; Roberto Meneghello; Gianmaria Concheri
Journal:  Appl Bionics Biomech       Date:  2018-02-01       Impact factor: 1.781

10.  The Effect of Pore Size Distribution and l-Lysine Modified Apatite Whiskers (HAP) on Osteoblasts Response in PLLA/HAP Foam Scaffolds Obtained in the Thermally Induced Phase Separation Process.

Authors:  Konrad Szustakiewicz; Marcin Włodarczyk; Małgorzata Gazińska; Karolina Rudnicka; Przemysław Płociński; Patrycja Szymczyk-Ziółkowska; Grzegorz Ziółkowski; Monika Biernat; Katarzyna Sieja; Michał Grzymajło; Piotr Jóźwiak; Sylwia Michlewska; Andrzej W Trochimczuk
Journal:  Int J Mol Sci       Date:  2021-03-30       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.